Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Oilminerdeluxe on Oct 03, 2022 7:58am

Wakey, wakey

Hands off snakey.


The Company intends to use the proceeds of the Financing for the following:

  • Good Laboratory Practice (“GLP”) toxicology study for intravenous installation of Rutherrin® intended for the treatment of Non-Small Lung Cancer (“NSCLC”) and Glio-Blastoma Multiforme (“GBM”), a fast-growing and aggressive brain tumor.
  • Advancement of Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC”) clinical study
  • Working capital and general corporate purposes

I wonder who bought this time. I will try and fetch a few today myself.

Time frame for this?
Comment by Legit62 on Oct 03, 2022 8:05am
Isnt this the same press release?? From the other day
Comment by Oilminerdeluxe on Oct 03, 2022 8:17am
Is it? But it says 3 Oct? Ok, maybe I made a complete fool of myself then for thinking it was another one he he
Comment by enriquesuave on Oct 03, 2022 8:24am
I believe it's another one "follow on" to close around October 14 in 11 days.  
Comment by Legit62 on Oct 03, 2022 8:51am
not listed on their website?? just curious
Comment by Infinity on Oct 03, 2022 8:59am
Looks like one more financing within 4 weeks??. What is going on here. Management blind siding all investors, without any notice!!
Comment by Infinity on Oct 03, 2022 9:15am
The bank lending rates are pushing companies towards equity financing. Makes good financial sense. My concern is why so soon. I would think equity financing, may be 6 months from now would be a more prudent decision. Hopefully at a much higher price. Perhaps at $.5 or 0.6 per share would generate more cash??
Comment by 99942Apophis on Oct 03, 2022 9:30am
Relax, may I suggest the company might have received request by investors wanting to get into the previous financial raise but were told it was filled. In my opinion the company could see an opportunity here to open an identical one to everyone  with todays notice. All just my opinion but I do think this will be filled easily by the closing date.
Comment by Rumpl3StiltSkin on Oct 03, 2022 9:43am
Well now they've done it, They clearly now have that $$ path to get to the many $$$ warrants due end of Aug 2024...   ;-)
Comment by socksnblonds642 on Oct 03, 2022 10:00am
Yup, could be a very exciting December. Giddyup. Insiders loading up. Company loading up on cash.
Comment by Impalaman on Oct 03, 2022 10:04am
Stocksnblonds---I agree with you----GIDDYUP___GO.
Comment by 99942Apophis on Oct 03, 2022 10:01am
Yes Rumpl3StiltSkin I see this more of a good-will gesture to boost investor relations since the window to participate is only 2 weeks.
Comment by CAinPlap on Oct 03, 2022 10:18am
They intended to raise $5 million when they first "announced" intention to raise. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250



USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse